FDA Brief

Warning letters Food

FDA warning letter to

Healthwest Minerals, Inc. dba Mt. Capra Products

High riskIssued Sep 11, 2024Posted Oct 1, 2024Division of Human and Animal Food Operations West VI

FDA says Mt. Capra marketed Goat Milk Formula Recipe Kit as a new infant formula without required 90-day premarket submission.

What happened

FDA reviewed mtcapra.com and the company’s Facebook page in March and April 2024 and found statements presenting the Goat Milk Formula Recipe Kit as a substitute for human milk or commercial infant formula. FDA determined the kit was a new infant formula (a formula the company had not previously manufactured and for which a submission to FDA is required) and that it was introduced without the required 90-day submission before marketing. After a May 7, 2024 teleconference, the company voluntarily recalled product distributed May 1, 2023 to May 1, 2024, notified customers, issued a May 10 press release, and removed the kit from sale.

What FDA found

  1. FDA determined the Goat Milk Formula Recipe Kit was an infant formula because the company represented it as a food for infants that simulates human milk or substitutes for human milk.

    section 201(z) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 321(z)]
  2. FDA determined the kit was a new infant formula because the company had not previously manufactured an infant formula.

    section 412(c)(2)(A) of the Act [21 U.S.C. § 350a(c)(2)(A)]; 21 CFR 106.3
  3. The company introduced the new infant formula into interstate commerce without making the required submission at least 90 days before marketing it.

    section 412(c)(1)(B) of the Act [21 U.S.C. § 350a(c)(1)(B)] and section 412(d)(1) [21 U.S.C. § 350a(d)(1)]
  4. The failure to make that submission before marketing is a prohibited act.

    section 301(s) of the Act [21 U.S.C. § 331(s)]

What FDA wants

FDA asks the company to notify it in writing within 15 working days of receipt of the letter of the specific steps it has taken to prevent recurrence of future violations. If the company believes its products were not in violation, FDA asks it to include its reasoning and supporting information.

Who should pay attention

  • companies selling homemade infant formula kits or ingredients
  • infant formula manufacturers and brands
  • retailers and online marketplaces that list infant-feeding products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Target Corporation

    FDA warns Target that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on store shelves in 20 states.

    High risk
  2. Walmart, Inc.

    Walmart kept recalled ByHeart infant formula on shelves in 21 states after a botulism outbreak recall, FDA says.

    High risk
  3. The Kroger Company

    FDA warned Kroger that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on its store shelves.

    High risk
  4. The Albertsons Companies Incorporated

    FDA warns Albertsons that recalled ByHeart infant formula tied to 51 infant botulism cases stayed on its store shelves for days.

    High risk